These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3494388)

  • 1. Effects of 1,25(OH)2D3 administration on serum bone GLA protein in predialysis chronic renal failure.
    Coen G; Mazzaferro S; Donato G; Massimetti C; Ballanti P; Bondatti F; Della Rocca C; Smacchi A; Mantazzoli F; Cinotti GA
    Adv Exp Med Biol; 1986; 208():297-303. PubMed ID: 3494388
    [No Abstract]   [Full Text] [Related]  

  • 2. Bone GLA protein in predialysis chronic renal failure. Effects of 1,25(OH)2D3 administration in a long-term follow-up.
    Coen G; Mazzaferro S; Bonucci E; Taggi F; Ballanti P; Bianchi AR; Donato G; Massimetti C; Smacchi A; Cinotti GA
    Kidney Int; 1985 Nov; 28(5):783-90. PubMed ID: 3878905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,25(OH)2D3 and 25-OHD3 in the treatment of renal osteodystrophy: comparison of combined versus 1,25(OH)2D3 administration alone.
    Coen G; Taccone Gallucci M; Bonucci E; Ballanti P; Bianchi AR; Bianchini G; Matteucci MC; Mazzaferro S; Picca S; Taggi F; Cinotti GA; Casciani CU
    Miner Electrolyte Metab; 1983; 9(1):19-27. PubMed ID: 6687749
    [No Abstract]   [Full Text] [Related]  

  • 4. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
    Lee SH; Huang TS; Hsieh SJ
    Miner Electrolyte Metab; 1996; 22(4):219-23. PubMed ID: 8807625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone aluminum content in predialysis chronic renal failure and its relation with secondary hyperparathyroidism and 1,25(OH)2D3 treatment.
    Coen G; Mazzaferro S; Costantini S; Ballanti P; Carrieri MP; Giordano R; Smacchi A; Sardella D; Bonucci E; Taggi F
    Miner Electrolyte Metab; 1989; 15(5):295-302. PubMed ID: 2811788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effects of histamine H2-receptor antagonists on serum parathyroid hormone in chronic renal failure.
    Fiore CE; Lunetta M; Kanis JA
    Clin Endocrinol (Oxf); 1985 Sep; 23(3):277-82. PubMed ID: 3878237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Osteocalcin in chronic hemodialysis patients as an additional parameter in the diagnosis of advanced secondary hyperparathyroidism].
    Motz W
    Acta Med Austriaca; 1989; 16(1):8-12. PubMed ID: 2785325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Procollagen type I C-terminal extension peptide in predialysis chronic renal failure.
    Coen G; Mazzaferro S; Ballanti P; Bonucci E; Bondatti F; Manni M; Pasquali M; Perruzza I; Sardella D; Spurio A
    Am J Nephrol; 1992; 12(4):246-51. PubMed ID: 1481872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels of bone Gla-protein reflect bone formation in patients on chronic maintenance dialysis.
    Malluche HH; Faugere MC; Fanti P; Price PA
    Kidney Int; 1984 Dec; 26(6):869-74. PubMed ID: 6335905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone turnover in rats treated with 1,25-dihydroxyvitamin D3, 25-hydroxyvitamin D3 or 24,25-dihydroxyvitamin D3.
    Mortensen BM; Gautvik KM; Gordeladze JO
    Biosci Rep; 1993 Feb; 13(1):27-39. PubMed ID: 8392394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of high-dose glucocorticoid administration on serum bone gamma carboxyglutamic acid-containing protein, serum alkaline phosphatase and vitamin D metabolites in normal subjects.
    Nielsen HK; Thomsen K; Eriksen EF; Charles P; Storm T; Mosekilde L
    Bone Miner; 1988 Apr; 4(1):105-13. PubMed ID: 3263890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ratio of parathyroid hormone to 1,25-dihydroxycholecalciferol in early renal failure.
    Lucas PA; Brown RC; Woodhead JS; Coles GA
    Kidney Int Suppl; 1983 Dec; 16():S171-4. PubMed ID: 6588249
    [No Abstract]   [Full Text] [Related]  

  • 13. Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3.
    Mortensen BM; Gordeladze JO; Lyngdal PT; Aarseth HP; Gautvik KM
    Miner Electrolyte Metab; 1993; 19(2):78-85. PubMed ID: 8377728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotype-associated changes in the effects of 1,25-dihydroxyvitamin D3 on alkaline phosphatase and bone GLA-protein of rat osteoblastic cells.
    Spiess YH; Price PA; Deftos JL; Manolagas SC
    Endocrinology; 1986 Apr; 118(4):1340-6. PubMed ID: 3485045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of calciferol and its metabolites on patients with chronic renal failure. II. Calcitriol, 1 alpha-hydroxyvitamin D3, and 24,25-dihydroxyvitamin D3.
    Voigts AL; Felsenfeld AJ; Llach F
    Arch Intern Med; 1983 Jun; 143(6):1205-11. PubMed ID: 6344827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of vitamin D3 metabolites in ovariectomized rats.
    Orimo H; Tsutsumi C; Hosoya N; Maeda Y; Yamato H; Katoh T
    J Int Med Res; 1989; 17(3):243-8. PubMed ID: 2788587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo regulation of chromogranin A messenger ribonucleic acid in the parathyroid by 1,25-dihydroxyvitamin D: studies in normal rats and in chronic renal insufficiency.
    Soliman E; Canaff L; Fox J; Hendy GN
    Endocrinology; 1997 Jun; 138(6):2596-600. PubMed ID: 9165053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parathyroid hormone suppression by 22-oxacalcitriol in the severe parathyroid hyperplasia.
    Funahashi H; Tanaka Y; Imai T; Wada M; Tsukamura K; Hayakawa Y; Matsuura N; Kikumori T; Oiwa M; Tominaga Y; Takagi H
    J Endocrinol Invest; 1998 Jan; 21(1):43-7. PubMed ID: 9633022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of secondary hyperparathyroidism of predialysis chronic renal failure with low doses of 1,25(OH)2D3: humoral and histomorphometric results.
    Coen G; Mazzaferro S; Bonucci E; Ballanti P; Massimetti C; Donato G; Landi A; Smacchi A; Della Rocca C; Cinotti GA
    Miner Electrolyte Metab; 1986; 12(5-6):375-82. PubMed ID: 3492662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of parathyroidectomy on circulating levels of 1 alpha,25-dihydroxyvitamin D and bone Gla protein in dialyzed patients.
    Fanti P; Smith AJ; Price PA; Reitz RE; Malluche HH
    J Clin Endocrinol Metab; 1986 May; 62(5):869-73. PubMed ID: 3485651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.